78 related articles for article (PubMed ID: 20088835)
1. Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20,000 samples.
Guntz P; Walter C; Schosseler P; Morel P; Coste J; Cazenave JP
Transfusion; 2010 May; 50(5):989-95. PubMed ID: 20088835
[TBL] [Abstract][Full Text] [Related]
2. An overview of the diagnostic tools.
Coste J
Transfus Clin Biol; 2013 Sep; 20(4):412-5. PubMed ID: 23928182
[TBL] [Abstract][Full Text] [Related]
3. Comparison of candidate vCJD in vitro diagnostic assays using identical sample sets.
Cooper JK; Ladhani K; Minor P
Vox Sang; 2012 Feb; 102(2):100-9. PubMed ID: 22126309
[TBL] [Abstract][Full Text] [Related]
4. Detection of misfolded prion protein in blood with conformationally sensitive peptides.
Pan T; Sethi J; Nelsen C; Rudolph A; Cervenakova L; Brown P; Orser CS
Transfusion; 2007 Aug; 47(8):1418-25. PubMed ID: 17655586
[TBL] [Abstract][Full Text] [Related]
5. PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease.
Herzog C; Rivière J; Lescoutra-Etchegaray N; Charbonnier A; Leblanc V; Salès N; Deslys JP; Lasmézas CI
J Virol; 2005 Nov; 79(22):14339-45. PubMed ID: 16254368
[TBL] [Abstract][Full Text] [Related]
6. The in vitro bioassay systems for the amplification and detection of abnormal prion PrP(Sc) in blood and tissues.
Zhang W; Wu J; Li Y; Carke RC; Wong T
Transfus Med Rev; 2008 Jul; 22(3):234-42. PubMed ID: 18572098
[TBL] [Abstract][Full Text] [Related]
7. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.
Edgeworth JA; Farmer M; Sicilia A; Tavares P; Beck J; Campbell T; Lowe J; Mead S; Rudge P; Collinge J; Jackson GS
Lancet; 2011 Feb; 377(9764):487-93. PubMed ID: 21295339
[TBL] [Abstract][Full Text] [Related]
8. Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG.
Neisser-Svae A; Bailey A; Gregori L; Heger A; Jordan S; Behizad M; Reichl H; Römisch J; Svae TE
Vox Sang; 2009 Oct; 97(3):226-33. PubMed ID: 19548963
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infection.
Segarra C; Bougard D; Moudjou M; Laude H; Béringue V; Coste J
PLoS One; 2013; 8(7):e69632. PubMed ID: 23894513
[TBL] [Abstract][Full Text] [Related]
10. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
[TBL] [Abstract][Full Text] [Related]
11. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
Chohan G; Llewelyn C; Mackenzie J; Cousens S; Kennedy A; Will R; Hewitt P
Transfusion; 2010 May; 50(5):1003-6. PubMed ID: 20230536
[TBL] [Abstract][Full Text] [Related]
12. An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.
Cervia JS; Sowemimo-Coker SO; Ortolano GA; Wilkins K; Schaffer J; Wortham ST
Transfus Med Rev; 2006 Jul; 20(3):190-206. PubMed ID: 16787827
[TBL] [Abstract][Full Text] [Related]
13. An immunoassay for the pathological form of the prion protein based on denaturation and time resolved fluorometry.
Dabaghian RH; Barnard G; McConnell I; Clewley JP
J Virol Methods; 2006 Mar; 132(1-2):85-91. PubMed ID: 16219367
[TBL] [Abstract][Full Text] [Related]
14. Variation in concentration of prion protein in the peripheral blood of patients with variant and sporadic Creutzfeldt-Jakob disease detected by dissociation enhanced lanthanide fluoroimmunoassay and flow cytometry.
Fagge T; Barclay GR; Macgregor I; Head M; Ironside J; Turner M
Transfusion; 2005 Apr; 45(4):504-13. PubMed ID: 15819670
[TBL] [Abstract][Full Text] [Related]
15. Technical aspects of the development and validation of tests for variant Creutzfeldt-Jakob disease in blood transfusion.
Minor PD
Vox Sang; 2004 Apr; 86(3):164-70. PubMed ID: 15078250
[TBL] [Abstract][Full Text] [Related]
16. Transfusion transmission of human prion diseases.
Zou S; Fang CT; Schonberger LB
Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Detection of Prions in Blood of Nonhuman Primates Infected with Variant Creutzfeldt-Jakob Disease.
Concha-Marambio L; Chacon MA; Soto C
Emerg Infect Dis; 2020 Jan; 26(1):34-43. PubMed ID: 31855141
[TBL] [Abstract][Full Text] [Related]
18. Prions and transfusion medicine.
Budka H
Vox Sang; 2000; 78 Suppl 2():231-8. PubMed ID: 10938959
[TBL] [Abstract][Full Text] [Related]
19. Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease.
Bougard D; Brandel JP; Bélondrade M; Béringue V; Segarra C; Fleury H; Laplanche JL; Mayran C; Nicot S; Green A; Welaratne A; Narbey D; Fournier-Wirth C; Knight R; Will R; Tiberghien P; Haïk S; Coste J
Sci Transl Med; 2016 Dec; 8(370):370ra182. PubMed ID: 28003547
[TBL] [Abstract][Full Text] [Related]
20. A sensitive and quantitative assay for normal PrP in plasma.
Gregori L; Gray BN; Rose E; Spinner DS; Kascsak RJ; Rohwer RG
J Virol Methods; 2008 May; 149(2):251-9. PubMed ID: 18339433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
